News from the healthcare data industry
November 10, 2022 08:00 AM Eastern Standard Time NEW YORK–(BUSINESS WIRE)–Castor, a leading provider of decentralized and hybrid clinical trial technology solutions, today announced a new offering to simplify post-marketing...
Clinerion launches its Federated Machine Learning Platform, a global, federated machine learning (ML) platform on its Patient Network Explorer infrastructure, incorporating its global network of partner hospitals. This new platform...
The first Fully Digital, Clinical Trial Solution for Oncology, Hematology & Urology CAMBRIDGE, Mass., Sept. 29, 2022 /PRNewswire/ — ConcertAI, LLC (ConcertAI) announced the launch of its new Digital Trial Software-as-a-Service solution. Powered...
Collaboration Utilizes RWD-enabled Capabilities Across Hospitals and Research Organizations to Transform the Elimination of Disparities NEW ORLEANS and CAMBRIDGE, Mass., Sept. 27, 2022 /PRNewswire/ — The National Cancer Institute Community Oncology Research Program (NCI...
By Jane Myles and Aaron Kamau The healthcare industry traditionally has used site-based clinical trials to assess the efficacy and safety of drugs and medical devices. Data collected from participants...
Oncology patients and clinical research sponsors benefit from Syapse’s real-world data intelligence and Science 37’s agile trial operating system to help accelerate the identification and participation of eligible participants August...
August 3, 2022 We all know that real-world data (RWD) from electronic health records (EHR) could boost clinical trial efficiency and improve patient outcomes – so what’s holding us back?...
Despite efforts to encourage the sharing of clinical trial data by drugmakers, the availability of this information to qualified researchers remains low, according to an investigative study appearing in JAMA Oncology this week....
At UCB, we see the many benefits of integrating technology in all aspects of our business to amplify the power of scientific innovation and to improve patient care. In the...
Only about half of a select group of clinical trials could be well-emulated with available real world evidence, according to the newly discussed results of an FDA pilot program. The...